CD8A and neoplasm: Mechanistically, <sup>125</sup>I promoted CD8α+T cell infiltration, activated ICD-related pathways, and triggered systemic antitumor immunity, as demonstrated by inhibition of distant tumor growth in the bilateral tumor system.